Not medical advice. This website is not medical advice, a diagnosis, a match to a trial, or a recommendation to join a study. Listings are plain-English rewrites of public ClinicalTrials.gov records. Whether a site is still enrolling, and whether you qualify, can only be confirmed by the study team and your clinician. Source registry: ClinicalTrials.gov. Editorial rules: methodology.
PlainTrials
RecruitingNot a traditional drug phaseinterventionalRules rewrite

Not a traditional drug phase: Primary Palliative Care Complex Intervention (PrimPal) for Palliative Care

This feasibility cluster-controlled randomly assigned trial (RCT) evaluates a complex intervention for the delivery of primary palliative care in Family Health Units (FHUs). The intervention consists of training General Practitioners (GPs) in palliative care through a 30 hour e-learning program and implementing a structured consultation model (4 consultations over 12 weeks) for adult patients with advanced chronic illness.

Official registry: https://clinicaltrials.gov/study/NCT07737899 · University of Coimbra · enrollment listed as 30

What this phase means

This study does not use the classic phase 1–4 drug ladder. It may be a device, a behavior program, a surgery timing study, or an early feasibility test.

Phase labels are FDA/ICH categories applied to the registry Phase field. They are not a finding that this study succeeded.

What the registry says happens

If you join, the listed intervention(s) are Primary Palliative Care Complex Intervention (PrimPal). The registry lists allocation as randomized. This feasibility cluster-controlled randomly assigned trial (RCT) evaluates a complex intervention for the delivery of primary palliative care in Family Health Units (FHUs).

They plan to enroll about 30 people at 2 sites. Taking part typically means study visits and measurements plus check-ins.

Official title (unrewritten)

Primary Palliative Care - a Feasibility Cluster Trial

Interventions: Primary Palliative Care Complex Intervention (PrimPal)

Primary outcome (registry wording): GP Feasibility Rate (Implementation Rate)

Who it is for (from inclusion criteria)

  • Ages 18 Years to any
  • Aged 18 years or older
  • Enrolled as a patient on the list of a recruited General Practitioner in one of the participating Family Health Units
  • Diagnosed with one or more of the following advanced chronic conditions:
  • Advanced-stage neoplasm (metastatic/stage IV cancer);
  • Chronic Obstructive Pulmonary Disease (COPD) - GOLD classification III or IV;
  • Congestive Heart Failure (CHF) - New York Heart Association (NYHA) functional classification III or IV;
  • Chronic Kidney Disease (CKD) - stage IV or V

Public study contact (from the registry)

Carlos S Cardoso, PhD

00351 239 857 700

carlosseicacardoso@uc.pt

Published on ClinicalTrials.gov. Contact them as a possible participant. They decide eligibility.

Sites listed on ClinicalTrials.gov

2 listed

Related recruiting trials in this snapshot

RecruitingNot a traditional drug phaseBethesda, Maryland
Immune System Related Kidney Disease

Kidney diseases related to the immune system include, nephrotic syndrome, glomerulonephritis, membranous nephropathy, lupus nephritis, and nephritis associated with connective tissue disorders. This study will allow researchers to admit and follow patients suffering from autoimmune diseases of the kidney.

NCT00001979 · Official ClinicalTrials.gov record · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

FAQ about this NCT record

Is NCT07737899 still recruiting?

The sponsor posted status “Recruiting” on ClinicalTrials.gov at last ingest. Sites can pause independently. Confirm with the official record and the listed contact.

What phase is NCT07737899?

Not a traditional drug phase. Phase labels are FDA/ICH categories applied to the registry Phase field. They are not a finding that this study succeeded.

Can PlainTrials tell me if I qualify for NCT07737899?

No. The inclusion and exclusion lists on this page are readable extracts of the public eligibility block. Only the study team can screen you.

How to read a ClinicalTrials.gov record · Questions to ask the coordinator · Glossary